Placebo infusion of .9 normal saline
Placebo infusion of .9 normal saline is a pharmaceutical drug with 2 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
2 source entries across 2 studies. This list may not include all unresolved or historical entries.
- Placebo infusion of .9 normal salineRegistry intervention
Linked study entry; product equivalence not established
View study and source - Placebo infusion of .9 normal salineRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
0
trials recruiting
2
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
The Effect of Magnesium Sulfate Infusion on the Quality of Recovery of Ambulatory Patients
Clinical Trials (2)
Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
The Effect of Magnesium Sulfate Infusion on the Quality of Recovery of Ambulatory Patients
All 2 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 2